Literature DB >> 23606335

The G60S connexin 43 mutation activates the osteoblast lineage and results in a resorption-stimulating bone matrix and abrogation of old-age-related bone loss.

Tanya Zappitelli1, Frieda Chen, Luisa Moreno, Ralph A Zirngibl, Marc Grynpas, Janet E Henderson, Jane E Aubin.   

Abstract

We previously isolated a low bone mass mouse, Gja1(Jrt) / + , with a mutation in the gap junction protein, alpha 1 gene (Gja1), encoding for a dominant negative G60S Connexin 43 (Cx43) mutant protein. Similar to other Cx43 mutant mouse models described, including a global Cx43 deletion, four skeletal cell conditional-deletion mutants, and a Cx43 missense mutant (G138R/ +), a reduction in Cx43 gap junction formation and/or function resulted in mice with early onset osteopenia. In contrast to other Cx43 mutants, however, we found that Gja1(Jrt) /+ mice have both higher bone marrow stromal osteoprogenitor numbers and increased appendicular skeleton osteoblast activity, leading to cell autonomous upregulation of both matrix bone sialoprotein (BSP) and membrane-bound receptor activator of nuclear factor-κB ligand (mbRANKL). In younger Gja1(Jrt) /+ mice, these contributed to increased osteoclast number and activity resulting in early onset osteopenia. In older animals, however, this effect was abrogated by increased osteoprotegerin (OPG) levels and serum alkaline phosphatase (ALP) so that differences in mutant and wild-type (WT) bone parameters and mechanical properties lessened or disappeared with age. Our study is the first to describe a Cx43 mutation in which osteopenia is caused by increased rather than decreased osteoblast function and where activation of osteoclasts occurs not only through increased mbRANKL but an increase in a matrix protein that affects bone resorption, which together abrogate age-related bone loss in older animals.
© 2013 American Society for Bone and Mineral Research.

Entities:  

Keywords:  AGE-RELATED BONE LOSS; BONE SIALOPROTEIN; CONNEXIN 43; OSTEOPENIA; RANKL-OPG SIGNALING

Mesh:

Substances:

Year:  2013        PMID: 23606335     DOI: 10.1002/jbmr.1965

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  14 in total

1.  High bone mass in mice lacking Cx37 because of defective osteoclast differentiation.

Authors:  Rafael Pacheco-Costa; Iraj Hassan; Rejane D Reginato; Hannah M Davis; Angela Bruzzaniti; Matthew R Allen; Lilian I Plotkin
Journal:  J Biol Chem       Date:  2014-02-07       Impact factor: 5.157

2.  Connexin 43 channels are essential for normal bone structure and osteocyte viability.

Authors:  Huiyun Xu; Sumin Gu; Manuel A Riquelme; Sirisha Burra; Danielle Callaway; Hongyun Cheng; Teja Guda; James Schmitz; Roberto J Fajardo; Sherry L Werner; Hong Zhao; Peng Shang; Mark L Johnson; Lynda F Bonewald; Jean X Jiang
Journal:  J Bone Miner Res       Date:  2015-03       Impact factor: 6.741

Review 3.  Gap junctional regulation of signal transduction in bone cells.

Authors:  Atum M Buo; Joseph P Stains
Journal:  FEBS Lett       Date:  2014-01-28       Impact factor: 4.124

Review 4.  Connexins and pannexins in the skeleton: gap junctions, hemichannels and more.

Authors:  Lilian I Plotkin; Joseph P Stains
Journal:  Cell Mol Life Sci       Date:  2015-06-20       Impact factor: 9.261

5.  Connexin43 enhances Wnt and PGE2-dependent activation of β-catenin in osteoblasts.

Authors:  Aditi Gupta; Saimai Chatree; Atum M Buo; Megan C Moorer; Joseph P Stains
Journal:  Pflugers Arch       Date:  2019-06-25       Impact factor: 3.657

Review 6.  Connexins in the skeleton.

Authors:  Joseph P Stains; Roberto Civitelli
Journal:  Semin Cell Dev Biol       Date:  2015-12-29       Impact factor: 7.727

7.  Up-regulation of BMP2/4 signaling increases both osteoblast-specific marker expression and bone marrow adipogenesis in Gja1Jrt/+ stromal cell cultures.

Authors:  Tanya Zappitelli; Frieda Chen; Jane E Aubin
Journal:  Mol Biol Cell       Date:  2015-01-07       Impact factor: 4.138

Review 8.  Role of connexins and pannexins during ontogeny, regeneration, and pathologies of bone.

Authors:  Lilian I Plotkin; Dale W Laird; Joelle Amedee
Journal:  BMC Cell Biol       Date:  2016-05-24       Impact factor: 4.241

9.  Elevated Levels of Peripheral Kynurenine Decrease Bone Strength in Rats with Chronic Kidney Disease.

Authors:  Bartlomiej Kalaska; Krystyna Pawlak; Tomasz Domaniewski; Ewa Oksztulska-Kolanek; Beata Znorko; Alicja Roszczenko; Joanna Rogalska; Malgorzata M Brzoska; Pawel Lipowicz; Michal Doroszko; Anna Pryczynicz; Dariusz Pawlak
Journal:  Front Physiol       Date:  2017-10-31       Impact factor: 4.566

10.  Osteocytic connexin 43 is not required for the increase in bone mass induced by intermittent PTH administration in male mice.

Authors:  R Pacheco-Costa; H M Davis; E G Atkinson; E Katchburian; L I Plotkin; R D Reginato
Journal:  J Musculoskelet Neuronal Interact       Date:  2016-03       Impact factor: 2.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.